Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA)
Clinical trial NCT03167619 · COMPLETED
Trial details
- NCT number
- NCT03167619
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-04
- Primary completion
- 2021-06-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.